EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells

Lining Chen, Yao Lu, Peng Xue, Yingying Lin, Zhen Zhang, Yuqi Wang, Yuning Zhang, Heng Quan, Yiran Wang, Huiyuan Guo

Food Frontiers · 2025-09 · 6 (5) · 2241-2254

DOI: 10.1002/fft2.70084 ↗

At a glance

Journal article in Food Frontiers, published online on 2025-07-29. Written by Lining Chen and 9 co-authors. Cited 4 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Key Research and Development Program of China.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Tumor cells have a competitive edge in nutrient uptake, leading to immune cell nutrient deprivation within the tumor microenvironment (TME) and suppressing anti‐tumor immunity. However, the key nutrient deprived by intestinal tumor cells and effective intervention strategies remains unidentified. Using organoid models and metabolomics, we clarified riboflavin as the most preferential nutrient for intestinal tumor cells over normal epithelial cells. After confirming in vitro that riboflavin supplementation did not promote tumor cell proliferation, we found in vivo that drinking water with riboflavin effectively inhibited murine colorectal tumor growth with enhanced intra‐tumoral CD8 + T‐cell cytotoxicity. We further demonstrated the indispensable role of adequate riboflavin in maintaining effector CD8 + T cells and revealed intestinal tumor cells overexpressed the riboflavin transporter SLC52A2, depleting riboflavin from CD8 + T cells and dampening their cytotoxicity, which can be restored by riboflavin supplementation. Our work clarified the critical nutrient and immune evasion mechanism, suggesting riboflavin supplementation as potential therapy to enhance anti‐tumor immunity in colorectal cancer.

Funding

  • National Key Research and Development Program of China

Cite

APA

Chen, L., Lu, Y., Xue, P., Lin, Y., Zhang, Z., Wang, Y., Zhang, Y., Quan, H., Wang, Y., & Guo, H. (2025). Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells. Food Frontiers, 6(5), 2241-2254. https://doi.org/10.1002/fft2.70084

Vancouver

Chen L, Lu Y, Xue P, Lin Y, Zhang Z, Wang Y, et al. Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells. Food Frontiers. 2025;6(5):2241-2254. doi:10.1002/fft2.70084

BibTeX
@article{Chen2025,
  author = {Chen, Lining and Lu, Yao and Xue, Peng and Lin, Yingying and Zhang, Zhen and Wang, Yuqi and Zhang, Yuning and Quan, Heng and Wang, Yiran and Guo, Huiyuan},
  title = {Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells},
  journal = {Food Frontiers},
  year = {2025},
  volume = {6},
  number = {5},
  pages = {2241--2254},
  doi = {10.1002/fft2.70084}
}
Start for free →